Unsupervised few shot learning architecture for diagnosis of periodontal disease in dental panoramic radiographs.

In the domain of medical imaging, the advent of deep learning has marked a significant progression, particularly in the nuanced area of periodontal disease diagnosis. This study specifically targets the prevalent issue of scarce labeled data in medical imaging. We introduce a novel unsupervised few-shot learning algorithm, meticulously crafted for classifying periodontal diseases using a limited collection of dental panoramic radiographs. Our method leverages UNet architecture for generating regions of interest (RoI) from radiographs, which are then processed through a Convolutional Variational Autoencoder (CVAE). This approach is pivotal in extracting critical latent features, subsequently clustered using an advanced algorithm. This clustering is key in our methodology, enabling the assignment of labels to images indicative of periodontal diseases, thus circumventing the challenges posed by limited datasets. Our validation process, involving a comparative analysis with traditional supervised learning and standard autoencoder-based clustering, demonstrates a marked improvement in both diagnostic accuracy and efficiency. For three real-world validation datasets, our UNet-CVAE architecture achieved up to average 14% higher accuracy compared to state-of-the-art supervised models including the vision transformer model when trained with 100 labeled images. This study not only highlights the capability of unsupervised learning in overcoming data limitations but also sets a new benchmark for diagnostic methodologies in medical AI, potentially transforming practices in data-constrained scenarios.

Prediction of Major Depressive Disorder Following Beta-Blocker Therapy in Patients with Cardiovascular Diseases.

Incident depression has been reported to be associated with poor prognosis in patients with cardiovascular disease (CVD), which might be associated with beta-blocker therapy. Because early detection and intervention can alleviate the severity of depression, we aimed to develop a machine learning (ML) model predicting the onset of major depressive disorder (MDD). A model based on L1 regularized logistic regression was trained against the South Korean nationwide administrative claims database to identify risk factors for the incident MDD after beta-blocker therapy in patients with CVD. We identified 50,397 patients initiating beta-blockers for CVD, with 774 patients developing MDD within 365 days after initiating beta-blocker therapy. An area under the receiver operating characteristic curve (AUC) of 0.74 was achieved. A history of non-selective beta-blockers and factors related to anxiety disorder, sleeping problems, and other chronic diseases were the most strong predictors. AUCs of 0.62-0.71 were achieved in the external validation conducted on six independent electronic health records and claims databases in the USA and South Korea. In conclusion, an ML model that identifies patients at high-risk for incident MDD was developed. Application of ML to identify susceptible patients for adverse events of treatment may serve as an important approach for personalized medicine.